glutathione pulmonary hypertension Pathophysiology and Management of Persistent of the Newborn Pathological Mechanisms and Potential Therapeutic
Pathological Mechanisms and Potential Therapeutic Targets of Pulmonary Arterial Hypertension: A Review New Drugs and Therapies in Pulmonary Arterial Hypertension Hyperuricemia and Hypoxic Pulmonary Hypertension: Pathogenic Links, Clinical Evidence, and Emerging Therapeutic Insights Cardiovascular Drugs and Therapy Springer Nature Link The progression of pulmonary arterial hypertension induced by monocrotaline is characterized by lung nitrosative and oxidative stress, and impaired pulmonary artery reactivity ScienceDirect Immunotherapy of Endothelin 1 Receptor Type A for Pulmonary Arterial Hypertension JACC
Pay in 4 interest-free payments of $7.09 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5



